C. Martínez

High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.

E. Shpall, P. Cagnoni, S. Matthes, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia—a randomized, placebo-controlled, double-blind safety and efficacy study

A. Ganser, L. Kanz, J. Szer, 2003, Annals of Hematology.

Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.

W. Franklin, E. Shpall, J. Glaspy, 1999, Blood.

Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients

A. Awada, T. Gil, F. Aoun, 2016, Journal of Endocrinological Investigation.

Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy

R. Salazar, J. Tabernero, J. Cancelas, 1999 .

Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy.

R. Salazar, J. Tabernero, J. Cancelas, 1999, Hematology.

New Approaches to the Management of Peripheral Vertigo: Efficacy and Safety of Two Calcium Antagonists in a 12-week, Multinational, Double-Blind Study

Carlo Pane Pianese, Lourdes Olivia Vales Hidalgo, Ramón Hinojosa González, 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

R. Bringas, G. Guillén, L. E. Fernández, 2019, Front. Oncol..